Ronald Blue Trust, Inc. Alkermes Plc. Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,702 shares of ALKS stock, worth $52,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,702
Previous 1,821
6.53%
Holding current value
$52,353
Previous $52,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$584 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$400 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$389 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$283 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.05B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...